231 related articles for article (PubMed ID: 27504587)
1. DNA-reactive B cells in lupus.
Suurmond J; Calise J; Malkiel S; Diamond B
Curr Opin Immunol; 2016 Dec; 43():1-7. PubMed ID: 27504587
[TBL] [Abstract][Full Text] [Related]
2. B cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus.
Jenks SA; Wei C; Bugrovsky R; Hill A; Wang X; Rossi FM; Cashman K; Woodruff MC; Aspey LD; Lim SS; Bao G; Drenkard C; Sanz I
Ann Rheum Dis; 2021 Sep; 80(9):1190-1200. PubMed ID: 34083207
[TBL] [Abstract][Full Text] [Related]
3. Precursor frequencies for DNA-specific B lymphocytes in patients with systemic lupus erythematosus (SLE).
Schwab J; Lukowsky A; Volk HD; Peter HH; Melchers I
Clin Exp Immunol; 1994 Jun; 96(3):450-7. PubMed ID: 8004815
[TBL] [Abstract][Full Text] [Related]
4. Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells.
Halcomb KE; Musuka S; Gutierrez T; Wright HL; Satterthwaite AB
Mol Immunol; 2008 Dec; 46(2):233-41. PubMed ID: 18849077
[TBL] [Abstract][Full Text] [Related]
5. Lupus susceptibility genes may breach tolerance to DNA by impairing receptor editing of nuclear antigen-reactive B cells.
Liu Y; Li L; Kumar KR; Xie C; Lightfoot S; Zhou XJ; Kearney JF; Weigert M; Mohan C
J Immunol; 2007 Jul; 179(2):1340-52. PubMed ID: 17617627
[TBL] [Abstract][Full Text] [Related]
6. Re-establishing tolerance to DNA in humanized and murine models of SLE.
Nikolova K; Mihaylova N; Voynova E; Kerekov N; Gesheva V; Prechl J; Nikolova M; Tchorbanov A
Autoimmun Rev; 2010 May; 9(7):499-502. PubMed ID: 20149897
[TBL] [Abstract][Full Text] [Related]
7. Development of pathogenic anti-DNA antibodies in patients with systemic lupus erythematosus.
Suzuki N; Mihara S; Sakane T
FASEB J; 1997 Oct; 11(12):1033-8. PubMed ID: 9337156
[TBL] [Abstract][Full Text] [Related]
8. Human pathogenic autoantibodies and their escape from deletion.
Zouali M
Ann N Y Acad Sci; 1995 Sep; 764():436-9. PubMed ID: 7486561
[No Abstract] [Full Text] [Related]
9. Class switching and consecutive loss of dsDNA-reactive B1a B cells from the peritoneal cavity during murine lupus development.
Enghard P; Humrich JY; Chu VT; Grussie E; Hiepe F; Burmester GR; Radbruch A; Berek C; Riemekasten G
Eur J Immunol; 2010 Jun; 40(6):1809-18. PubMed ID: 20333624
[TBL] [Abstract][Full Text] [Related]
10. Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential.
Zhang J; Jacobi AM; Wang T; Berlin R; Volpe BT; Diamond B
J Autoimmun; 2009; 33(3-4):270-4. PubMed ID: 19398190
[TBL] [Abstract][Full Text] [Related]
11. Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice.
Tchorbanov AI; Voynova EN; Mihaylova NM; Todorov TA; Nikolova M; Yomtova VM; Chiang BL; Vassilev TL
Eur J Immunol; 2007 Dec; 37(12):3587-96. PubMed ID: 18034421
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic characterization of autoreactive B cells--checkpoints of B cell tolerance in patients with systemic lupus erythematosus.
Jacobi AM; Zhang J; Mackay M; Aranow C; Diamond B
PLoS One; 2009 Jun; 4(6):e5776. PubMed ID: 19488401
[TBL] [Abstract][Full Text] [Related]
13. The role of somatic hypermutation in the generation of pathogenic antibodies in SLE.
Schroeder K; Herrmann M; Winkler TH
Autoimmunity; 2013 Mar; 46(2):121-7. PubMed ID: 23181829
[TBL] [Abstract][Full Text] [Related]
14. Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells.
Grimaldi CM
Curr Opin Rheumatol; 2006 Sep; 18(5):456-61. PubMed ID: 16896282
[TBL] [Abstract][Full Text] [Related]
15. The role of toll-like receptors in systemic lupus erythematosus.
Rahman AH; Eisenberg RA
Springer Semin Immunopathol; 2006 Oct; 28(2):131-43. PubMed ID: 17047954
[TBL] [Abstract][Full Text] [Related]
16. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.
Wen X; Zhang D; Kikuchi Y; Jiang Y; Nakamura K; Xiu Y; Tsurui H; Takahashi K; Abe M; Ohtsuji M; Nishimura H; Takatsu K; Shirai T; Hirose S
Eur J Immunol; 2004 Oct; 34(10):2740-9. PubMed ID: 15368290
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a germline Vk gene encoding cationic anti-DNA antibody and role of receptor editing for development of the autoantibody in patients with systemic lupus erythematosus.
Suzuki N; Harada T; Mihara S; Sakane T
J Clin Invest; 1996 Oct; 98(8):1843-50. PubMed ID: 8878436
[TBL] [Abstract][Full Text] [Related]
18. Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA.
Zhao J; Giles BM; Taylor RL; Yette GA; Lough KM; Ng HL; Abraham LJ; Wu H; Kelly JA; Glenn SB; Adler AJ; Williams AH; Comeau ME; Ziegler JT; Marion M; Alarcón-Riquelme ME; ; Alarcón GS; Anaya JM; Bae SC; Kim D; Lee HS; Criswell LA; Freedman BI; Gilkeson GS; Guthridge JM; Jacob CO; James JA; Kamen DL; Merrill JT; Sivils KM; Niewold TB; Petri MA; Ramsey-Goldman R; Reveille JD; Scofield RH; Stevens AM; Vilá LM; Vyse TJ; Kaufman KM; Harley JB; Langefeld CD; Gaffney PM; Brown EE; Edberg JC; Kimberly RP; Ulgiati D; Tsao BP; Boackle SA
Ann Rheum Dis; 2016 Jan; 75(1):242-52. PubMed ID: 25180293
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
[TBL] [Abstract][Full Text] [Related]
20. Regulatory and pathogenetic mechanisms of autoantibodies in SLE.
Radic M; Herrmann M; van der Vlag J; Rekvig OP
Autoimmunity; 2011 Aug; 44(5):349-56. PubMed ID: 21231891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
